Glycorex Transplantation AB is a Lund-based medical device company developing carbohydrate-based adsorption technologies for transplantation medicine and immunotherapy. Their key product, Glycosorb-ABO, is a column used to remove blood group antibodies enabling ABO-incompatible organ and stem cell transplantation. Founded in 1998 and listed on Nasdaq First North, Glycorex employs around 20 people and has regulatory approvals across Europe and in select international markets.
glycorex.comPart of: Skåne Startup map